TNXP - Tonix Pharmaceuticals Holding Corp.

QQQ $ 454.82 $ -3.24 (-0.7 %)

DIA $ 398.57 $ -4.02 (-1.03 %)

SPY $ 530.36 $ -3.71 (-0.7 %)

TLT $ 91.26 $ -1.09 (-1.21 %)

GLD $ 225.37 $ -2.03 (-0.93 %)

Previous Close

$ 0.1717

Open

$ 0.17

Bid

$ 0.17 x 800

Ask

$ 0.00 x 0

Day's Range

$ 0.17 - $ 0.17

52 Week Range

$ 0.12 - $ 2.10

Volume

1,821,245

Average Volume

Market Cap

13.89M

Beta (5Y Monthly)

$ -0.01

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-13-2024	03-31-2024	10-Q
2	04-01-2024	12-31-2023	10-K
3	11-09-2023	09-30-2023	10-Q
4	08-10-2023	06-30-2023	10-Q
5	05-08-2023	03-31-2023	10-Q
6	03-13-2023	12-31-2022	10-K
7	11-07-2022	09-30-2022	10-Q
8	08-08-2022	06-30-2022	10-Q
9	05-09-2022	03-31-2022	10-Q
10	03-14-2022	12-31-2021	10-K
11	11-08-2021	09-30-2021	10-Q
12	08-09-2021	06-30-2021	10-Q
13	05-10-2021	03-31-2021	10-Q
14	03-15-2021	12-31-2020	10-K
15	11-09-2020	09-30-2020	10-Q
16	08-10-2020	06-30-2020	10-Q
17	05-12-2020	03-31-2020	10-Q
18	03-24-2020	12-31-2019	10-K
19	11-08-2019	09-30-2019	10-Q
20	08-12-2019	06-30-2019	10-Q
21	05-13-2019	03-31-2019	10-Q
22	03-18-2019	12-31-2018	10-K
23	11-09-2018	09-30-2018	10-Q
24	08-13-2018	06-30-2018	10-Q
25	05-11-2018	03-31-2018	10-Q
26	03-09-2018	12-31-2017	10-K
27	11-06-2017	09-30-2017	10-Q
28	08-11-2017	06-30-2017	10-Q
29	05-12-2017	03-31-2017	10-Q
30	04-13-2017	12-31-2016	10-K
31	11-10-2016	09-30-2016	10-Q
32	08-05-2016	06-30-2016	10-Q
33	05-06-2016	03-31-2016	10-Q
34	03-03-2016	12-31-2015	10-K
35	11-06-2015	09-30-2015	10-Q
36	08-07-2015	06-30-2015	10-Q
37	05-08-2015	03-31-2015	10-Q
38	02-27-2015	12-31-2014	10-K
39	11-07-2014	09-30-2014	10-Q
40	08-08-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Tonix Pharmaceuticals To Present Study Inv...
05/29/2024 12:04:31

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with mar...

Tonix Pharmaceuticals Plans To Reduce Its ...
05/22/2024 21:26:47

At this time the Company has made a good faith determination that it does not expect to incur a material charge in connection w...

Tonix Pharmaceuticals To Deliver Oral Pres...
05/22/2024 12:18:32

Oral Presentation of Tonmya™ (TNX-102 SL) for Fibromyalgia; NDA preparation in progress Posters Highlighting Other TNX-102 SL P...

Tonix Pharmaceuticals Reports Key Findings...
05/21/2024 12:14:51

Tonmya is a potential new first-line, centrally acting non-opioid analgesic for the management of fibromyalgia, supported by st...

Tonix Pharmaceuticals Q1 2024 GAAP EPS $(0...
05/13/2024 20:42:12

Tonix Pharmaceuticals (NASDAQ:TNXP) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of...

WHO's Tedros Adhanom Ghebreyesus Posts On ...
04/11/2024 14:09:23

https://twitter.com/DrTedros/status/1778423967105139108

Tonix Pharmaceuticals Q4 EPS $(0.86) Beats...
04/01/2024 20:28:39

Tonix Pharmaceuticals (NASDAQ:TNXP) reported quarterly losses of $(0.86) per share which beat the analyst consensus estimate of...

tonix-pharmaceuticals-stock-tnxp-hits-a-new-all-time-low-whats-going-on

Tonix Pharmaceuticals Stock (TNXP) Hits A ...
04/01/2024 14:43:24

Tonix Pharmaceuticals shares are trading lower by 7.2% Monday. The company last week announced the pricing of a $4.4 million re...

12-health-care-stocks-moving-in-fridays-intraday-session

12 Health Care Stocks Moving In Friday's I...
03/29/2024 16:30:53

why-kodiak-sciences-shares-are-trading-lower-by-around-20-here-are-other-stocks-moving-in-thursdays-mid-day-session

Why Kodiak Sciences Shares Are Trading Low...
03/28/2024 18:08:52

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-e...

why-tonix-pharmaceuticals-stock-tnxp-is-getting-obliterated

Why Tonix Pharmaceuticals Stock (TNXP) Is ...
03/28/2024 17:02:53

Tonix Pharmaceuticals shares are trading lower by 22.3% Thursday afternoon. The company announced the pricing of a $4.4 million...

12-health-care-stocks-moving-in-thursdays-intraday-session

12 Health Care Stocks Moving In Thursday's...
03/28/2024 16:31:26

Tonix Pharmaceuticals Prices $4.4M Registe...
03/28/2024 13:35:31

Tonix Pharmaceuticals Receives Rare Pediat...
03/25/2024 12:06:31

TNX-2900 is a proprietary magnesium-potentiated formulation of intranasal oxytocin, a naturally occurring hormone that reduces ...

Tonix Pharmaceuticals Announces Poster Pre...
03/21/2024 12:07:10

Four Phase 2 investigator-initiated studies of TNX-1900 (intranasal potentiated oxytocin) are ongoing for pediatric obesity, bi...

Tonix Pharmaceuticals Announces Selection ...
03/20/2024 12:04:34

Tonix Pharmaceuticals Announces Transition...
03/19/2024 12:04:09

Zembrace® SymTouch® and Tosymra® will be marketed by Tonix Medicines, Tonix's wholly-owned commercial subsidiary Commercial...

Tonix Pharmaceuticals Announces Phase 3 RE...
03/11/2024 12:02:45

Tonix Pharmaceuticals Announces Publicatio...
03/07/2024 13:10:29

Data support evaluation of the effects of two weeks of TNX-102 SL therapy on severity of acute stress reaction (ASR) and freque...

Tonix Pharmaceuticals Selects EVERSANA To ...
03/06/2024 13:12:36

Tonmya is a potential new first-line, centrally acting non-opioid analgesic for the management of fibromyalgia, supported by st...